Ovid Therapeutics
OVID
#7730
Rank
HK$3.25 B
Marketcap
HK$17.24
Share price
-5.98%
Change (1 day)
58.28%
Change (1 year)

EPS for Ovid Therapeutics (OVID)

EPS in 2026 (TTM): -HK$2.42

According to Ovid Therapeutics 's latest financial reports the company's current EPS (TTM) is -HK$2.43. In 2025 the company made an earnings per share (EPS) of -HK$2.43 an increase over its 2024 EPS that were of -HK$2.98.

EPS history for Ovid Therapeutics from 2017 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-HK$2.42-0.24%
2025-HK$2.43-18.42%
2024-HK$2.98
2022-HK$6.04-143.5%
2021HK$13.87-226.43%
2020-HK$10.97-11.39%
2019-HK$12.38-25.47%
2018-HK$16.62-24.06%
2017-HK$21.88

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
-HK$10.58 335.48%๐Ÿ‡บ๐Ÿ‡ธ USA